Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis
Crossref DOI link: https://doi.org/10.1007/s11523-017-0486-5
Published Online: 2017-03-29
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Xiu-Wei
Ma, Yu-Xiang
Sun, Yang
Cao, Yu-Bo
Li, Qin
Xu, Chong-An
License valid from 2017-03-29